Everett J. Moding

Stanford University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index4.8kcitations170works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(71), Cancer Immunotherapy and Biomarkers(35), Sarcoma Diagnosis and Treatment(33), Lung Cancer Treatments and Mutations(28), Epigenetics and DNA Methylation(18)

Publications170 total

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma
Clinical Cancer Research·2026
Supplementary Fig. 2 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
2025Open Access
Supplementary Fig. 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
2025Open Access
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy
Immunity·2025Open Access
Multidimensional Single-Cell Transcriptomic Profiling of Uterine Leiomyosarcomas Identifies Molecular Subtypes with Distinct Therapeutic Vulnerabilities
2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
2025Open Access
Multimodal discovery of distinct tumor ecosystems for classic Hodgkin lymphoma
Blood·2025Open Access
High throughput mutational characterization of the GPCR ligand C5a using yeast display and deep sequencing
Structure·2025Open Access
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma
Nature Communications·2025Open Access
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Cancers·2025· 1 citedOpen Access
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics
Genome Medicine·2025· 2 citedOpen Access
Data from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Figures S1-S8 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Table S1-S10 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
2025Open Access
Whole genome-based circulating tumor DNA analysis as an ultrasensitive biomarker in pediatric sarcomas.
Journal of Clinical Oncology·2025
Tegavivint triggers TECR-dependent nonapoptotic cancer cell death
Nature Chemical Biology·2025· 4 cited
3086 Three year experience of clinical Implementation of an Automated VMAT Treatment Planning Script for Head and Neck Cancer Patients
Radiotherapy and Oncology·2025
Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult Patients
Cancers·2025· 1 citedOpen Access
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
Cancer Discovery·2025· 10 citedOpen Access
Abstract 3705: <i>In silico</i> modeling of ctDNA shedding using a novel computational pipeline which models tumorigenesis, progression, and metastasis
Cancer Research·2025
page 1 of 9Next →

Frequent Co-authors

David G. Kirsch(20), Maximilian Diehn(17), Ash A. Alizadeh(14), Jacob J. Chabon(13), Chang‐Lung Lee(11), Yan Ma(9), Emily G. Hamilton(8), David M. Kurtz(8), Barzin Y. Nabet(8), Chih Long Liu(7), Heather A. Wakelee(7), Rene F. Bonilla(6), Joel W. Neal(6), Billy W. Loo(6), Michael S. Binkley(6), Mohammad Shahrokh Esfahani(5), Henning Stehr(5), Aadel A. Chaudhuri(5), Christopher H. Yoo(5), Ryan B. Ko(5)